门静脉血栓形成危险因素的研究进展
Research Progress on Risk Factors of Portal Vein Thrombosis in Cirrhosis
DOI: 10.12677/ACM.2022.121094, PDF,   
作者: 贺业群*, 刘一品:滨州医学院烟台附属医院消化内科,山东 烟台
关键词: 门静脉血栓炎症因子危险因素血液流变学Portal Vein Thrombosis Inflammatory Factor Risk Factors Hemodynamic
摘要: 门静脉血栓(portal venous thrombosis, PVT)是一种深静脉血栓,不仅会出现在肝硬化患者中,非肝硬化患者也可能形成PVT,临床症状复杂多样,严重时会危及生命。近年来,PVT的发生率越来越高,但发病隐匿,大多数患者都是在常规检查、筛查肝癌及肝移植前准备中偶然发现,所以尽早明确PVT形成的危险因素有利于早期诊断,并及时采取相应措施。本文就门静脉血栓形成危险因素的研究进展进行探究和分析,以确定PVT高危人群。
Abstract: Portal Venous thrombosis (PVT) is a deep vein thrombosis that can occur not only in patients with cirrhosis, but also in non-cirrhotic patients. The clinical symptoms are complex and varied, and can be life-threatening in serious cases. In recent years, the incidence of PVT is increasing, but the onset is hidden, and most patients are accidentally discovered during routine examination, screening for liver cancer and preparation for liver transplantation. Therefore, early identification of risk factors for PVT is conducive to early diagnosis, and corresponding measures should be taken as soon as possible. In this paper, the research progress on risk factors of portal vein thrombosis was explored and analyzed to identify individuals at high risk for PVT.
文章引用:贺业群, 刘一品. 门静脉血栓形成危险因素的研究进展[J]. 临床医学进展, 2022, 12(1): 633-639. https://doi.org/10.12677/ACM.2022.121094

参考文献

[1] Ai, M.H., Dong, W.G., Tan, X.P., et al. (2020) Efficacy and Safety Study of Direct-Acting Oral Anticoagulants for the Treatment of Chronic Portal Vein Thrombosis in Patients with Liver Cirrhosis. European Journal of Gastroenterology and Hepatology, 32, 1395-1400. [Google Scholar] [CrossRef
[2] Fimognari, F.L. and Violi, F. (2008) Portal Vein Thrombosis in Liver Cirrhosis. Internal and Emergency Medicine, 3, 213-218. [Google Scholar] [CrossRef] [PubMed]
[3] Stine, J.G., Shah, P.M., Cornella, S.L., et al. (2015) Portal Vein Thrombosis, Mortality and Hepatic Decompensation in Patients with Cirrhosis: A Meta-Analysis. World Journal of Hepatology, 7, 2774-2780. [Google Scholar] [CrossRef] [PubMed]
[4] Qi, X., Su, C., Ren, W., et al. (2015) Association between Portal Vein Thrombosis and Risk of Bleeding in Liver Cirrhosis: A Systematic Review of the Literature. Clinics and Research in Hepatology and Gastroenterology, 39, 683-691. [Google Scholar] [CrossRef] [PubMed]
[5] Violi, F. and Ferro, D. (2013) Clotting Activation and Hyperfibrinolysis in Cirrhosis: Implication for Bleeding and Thrombosis. Seminars in Thrombosis and Hemostasis, 39, 426-433. [Google Scholar] [CrossRef] [PubMed]
[6] Majid, Z., Tahir, F., Bin Arif, T. and Ahmed, J. (2020) Chronic Non-Cirrhotic Portal Vein Thrombosis with Cavernous Transformation Secondary to Protein C and S Deficiency. Cureus, 12, e7142. [Google Scholar] [CrossRef] [PubMed]
[7] Shi, D., Xu, X., Xu, Z., et al. (2014) P-Selectin: An Unpredicted Factor for Deep Vein Thrombosis after Total Hip Arthroplasty. BioMed Research International, 2014, 783967-783972. [Google Scholar] [CrossRef] [PubMed]
[8] Wei, Y., Chen, X., Shen, H., et al. (2018) P-Selectin Level at First and Third Day after Portal Hypertensive Splenectomy for Early Prediction of Portal Vein Thrombosis in Patients with Cirrhosis. Clinical and Applied Thrombosis/Hemostasis, 24, 76S-83S. [Google Scholar] [CrossRef] [PubMed]
[9] Dai, J., Qi, X., Peng, Y., et al. (2015) Association between D-Dimer Level and Portal Venous System Thrombosis in Liver Cirrhosis: A Retrospective Observational Study. International Journal of Clinical and Experimental Medicine, 8, 15296-15301.
[10] 刘瑞红, 廉恒丽. P-选择素和D二聚体对肝硬化门静脉血栓形成的早期预测价值[J]. 血栓与止血学, 2021, 27(6): 974-976. DOI:10.3969/j.issn.1009-6213.2021.06.031
[11] Violi, F., Corazza, G.R., Caldwell, S.H., et al. (2016) Portal Vein Thrombosis Relevance on Liver Cirrhosis: Italian Venous Thrombotic Events Registry. Internal and Emergency Medicine, 11, 1059-1066. [Google Scholar] [CrossRef] [PubMed]
[12] 张延峰, 张磊, 张凯. 肝硬化门静脉血栓患者形成的相关因素分析[J]. 血栓与止血学, 2022, 28(5): 796-798. DOI:10.3969/j.issn.1009-6213.2022.05.035
[13] Buliarca, A., Horhat, A., Mocan, T., Craciun, R., Procopet, B. and Sparchez, Z. (2021) Viscoelastic Tests in Liver Disease: Where Do We Stand Now? World Journal of Gastroenterology, 27, 3290-3302. [Google Scholar] [CrossRef] [PubMed]
[14] Stine, J.G., Wang, J., Shah, P.M., et al. (2018) Decreased Portal Vein Velocity Is Predictive of the Development of Portal Vein Thrombosis: A Matched Case-Control Study. Hepatology, 38, 94-101. [Google Scholar] [CrossRef] [PubMed]
[15] Huang, D., Tao, M., Cao, L., Wang, X., Zheng, S. and Cao, Y. (2019) Risk Factors and Anticoagulation Effects of Portal Vein System Thrombosis after Laparoscopic Splenectomy in Patients with or without Cirrhosis. Surgical Laparoscopy Endoscopy & Percutaneous Techniques, 29, 498-502. [Google Scholar] [CrossRef
[16] Iba, T. and Levy, J.H. (2018) Inflammation and Thrombosis: Roles of Neutrophils, Platelets and Endothelial Cells and Their Interactions in Thrombus Formation during Sepsis. Journal of Thrombosis and Haemostasis, 16, 231-241. [Google Scholar] [CrossRef] [PubMed]
[17] Villa, E., Camma, C., Marietta, M., et al. (2012) Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients with Advanced Cirrhosis. Gastroenterology, 143, 1253-1260.e4. [Google Scholar] [CrossRef] [PubMed]
[18] Huang, X., Fan, X., Zhang, R., Jiang, S., Yang, K. and Chen, S. (2020) Systemic Inflammation and Portal Vein Thrombosis in Cirrhotic Patients with Gastroesophageal Varices. European Journal of Gastroenterology and Hepatology, 32, 401-405. [Google Scholar] [CrossRef
[19] Plessier, A., Darwish-Murad, S., Hernandez-Guerra, M., et al. (2010) Acute Portal Vein Thrombosis Unrelated to Cirrhosis: A Prospective Multicenter Follow-Up Study. Hepatology, 51, 210-218. [Google Scholar] [CrossRef] [PubMed]
[20] Giannitrapani, L., Grana, W, Licata, A., Schiavone, C., Montalto, G. and Soresi, M. (2018) Nontumorous Portal Vein Thrombosis in Liver Cirrhosis: Possible Role of β-Blockers. Medical Principles and Practice, 27, 466-471. [Google Scholar] [CrossRef] [PubMed]
[21] Zampino, R., Lebano, R., Coppola, N., et al. (2018) The Use of Nonselective Beta Blockers Is a Risk Factor for Portal Vein Thrombosis in Cirrhotic Patients. Saudi Journal of Gastroenterology, 24, 25-29. [Google Scholar] [CrossRef
[22] 刘倩, 张锦, 段小霞, 等. 血栓弹力图、常规凝血试验在肝硬化并门静脉血栓中的诊断价值[J]. 中国临床医生杂志, 2021, 49(10): 1181-1185. [Google Scholar] [CrossRef
[23] Miko, I., Nemeth, N., Sogor, V., et al. (2017) Comparative Erythrocyte Deformability Investigations by Filtrometry, Slit-Flow and Rotational Ektacytometry in a Longterm Follow-Up Animal Study on Splenectomy and Different Spleen Preserving Operative Techniques: Partial or Subtotal Spleen Resection and Spleen Autotransplantation. Clinical Hemorheology and Microcirculation, 66, 83-96. [Google Scholar] [CrossRef
[24] Shiraishi, K., Tsuruya, K., Anzai, K., et al. (2015) Effects of Ethanol and Acetaldehyde Load on Erythrocyte Deformability in Healthy Subjects and Patients with Liver Cirrhosis. Nihon Arukoru Yakubutsu Igakkai Zasshi, 50, 13-18.
[25] Tikhomirova, I., Petrochenko, E., Malysheva, Y., et al. (2016) Interrelation of Blood Coagulation and Hemorheology in Cancer. Clinical Hemorheology and Microcirculation, 64, 635-644. [Google Scholar] [CrossRef
[26] Hayashi, Y., Brun, M.A., Machida, K., et al. (2017) Simultaneous Assessment of Blood Coagulation and Hematocrit Levels in Dielectric Blood Coagulometry. Biorheology, 54, 25-35. [Google Scholar] [CrossRef
[27] Huang, L., Yu, Q., Peng, H. (2021) Hemorheological Alteration in Patients with Cirrhosis Clinically Diagnosed with Portal Vein System Thrombosis after Splenectomy. Medical Science Monitor, 27, e931157. [Google Scholar] [CrossRef
[28] Yeo, J.W., Law, M.S.N., Lim, J.C.L., et al. (2021) Meta-Analysis and Systematic Review: Prevalence, Graft Failure, Mortality, and Post-Operative Thrombosis in Liver Transplant Recipients with Pre-Operative Portal Vein Thrombosis. Clinical Transplantation, e14520. [Google Scholar] [CrossRef] [PubMed]
[29] Pere, G., Basselerie, H., Maulat, C., et al. (2021) Splenic Volume and Splenic Vein Diameter Are Independent Pre-Operative Risk Factors of Portal Vein Thrombosis after Splenectomy: A Retrospective Cohort Study. BMC Surgery, 21, Article No. 366. [Google Scholar] [CrossRef] [PubMed]
[30] Baba, M., Fakhoury, J. and Syed, A. (2015) Portal Vein Thrombosis Due to Prothrombin Gene Mutation Following Sleeve Gastrectomy. Case Reports in Gastrointestinal Medicine, 2015, Article ID: 816914. [Google Scholar] [CrossRef] [PubMed]
[31] Ma, S.D., Wang, J., Bezinover, D., Kadry, Z., Northup, P.G. and Stine, J.G. (2019) Inherited Thrombophilia and Portal Vein Thrombosis in Cirrhosis: A Systematic Review and Meta-Analysis. Research and Practice in Thrombosis and Haemostasis, 3, 658-667. [Google Scholar] [CrossRef] [PubMed]
[32] Cernera, G., Di Minno, A., Amato, F., et al. (2020) Molecular Analysis of Prothrombotic Gene Variants in Venous Thrombosis: A Potential Role for Sex and Thrombotic Localization. Journal of Clinical Medicine, 9, 1008. [Google Scholar] [CrossRef] [PubMed]
[33] Hosoda, T. and Orikasa, H. (2021) A Fatal Case of Extensive Gastrointestinal Necrosis Due to Portal and Mesenteric Vein Thrombosis in the Post-Acute Phase of COVID-19. Journal of Infection and Chemotherapy, 28, 108-111. [Google Scholar] [CrossRef] [PubMed]
[34] Ayala, R., Grande, S., Bustelos, R., et al. (2012) Obesity Is an Independent Risk Factor for Pre-Transplant Portal Vein Thrombosis in Liver Recipients. BMC Gastroenterology, 12, Article No. 114. [Google Scholar] [CrossRef
[35] 钟燕, 郭辉. 糖尿病酮症酸中毒合并急性坏死性胰腺炎、门静脉血栓形成1例[J]. 中国煤炭工业医学杂志, 2014(9): 1487-1488. 11723/mtgyyx1007-9564201409038 [Google Scholar] [CrossRef